Medical News

RSS

Oral contraceptives may have a potential role in the management of premenopausal women with asthma

New research shows that during natural menstrual cycles, women with asthma who were not taking oral contraceptives (OC) had lower exhaled nitric oxide levels (eNO), a marker of airway inflammation associated with asthma, than women who were taking OC.

5 Nov 2009

InterMune seeks FDA marketing approval for pirfenidone

InterMune, Inc. today announced that it has submitted an electronic New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF). Pirfenidone has been granted Orphan Drug and Fast Track designation by the FDA, and also has been granted Orphan Drug status in Europe.

5 Nov 2009

Savvis incorporates Vitality's wellness program to help improve employees’ health challenges

The Vitality Group today announced that Savvis, Inc. has selected its incentive-based wellness program to motivate and support Savvis associates as they take ownership of their personal health.

5 Nov 2009

Yoga may be more effective for reducing chronic low back pain, say researchers

Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center found that yoga may be more effective than standard treatment for reducing chronic low back pain in minority populations. This study appears in the November issue of Alternative Therapies in Health and Medicine.

5 Nov 2009

Raptor Pharmaceutical to present oral AMPA-kainate antagonist data at the neuropathic pain conference

Raptor Pharmaceutical Corp., today announced that data from a clinical trial of NGX426, the Company's orally administered non-opioid, AMPA/kainate antagonist, will be presented at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain, to be held November 20-21, 2009 in San Francisco.

5 Nov 2009

Patient enrollment in three late-stage clinical trials completed

Inspire Pharmaceuticals, Inc. announced today patient enrollment is complete in three of its late-stage clinical trials.

5 Nov 2009

Significant behavioral changes needed to maintain weight loss

Americans continue to get heavier. Most weight control methods short of bariatric surgery are generally considered ineffective in preventing obesity or reducing weight. The term energy gap was coined to estimate the change in energy balance (intake and expenditure) behaviors required to achieve and sustain reduced body weight outcomes in individuals and populations.

5 Nov 2009

AAHC urges Senator Harry Reid to incorporate its recommendations in the health reform legislation

Dr. Steven A. Wartman, president and CEO of the Association of Academic Health Centers (AAHC), urged Senate Majority Leader Harry Reid to ensure that health reform create an integrated, coordinated national health workforce policy by incorporating four AAHC recommendations into Senate health reform legislation.

5 Nov 2009

Herbalife establishes new business in Vietnam; Paraguay operations set to begin shortly

Herbalife Ltd., a global nutrition and direct-selling company, announced that it has begun operations in Vietnam, making this the 71st country where the company conducts business. On November 16, operations will begin in Paraguay.

5 Nov 2009

Tetracycline-like compound raises hope for treatment of spinal muscular atrophy

A chemical cousin of the common antibiotic tetracycline might be useful in treating spinal muscular atrophy (SMA), a currently incurable disease that is the leading genetic cause of death in infants. This is the finding of a research collaboration involving Adrian Krainer, Ph.D., of Cold Spring Harbor Laboratory (CSHL) and scientists from Paratek Pharmaceuticals and Rosalind Franklin University of Medicine and Science.

5 Nov 2009

Researchers develop new molecular tools to investigate Alzheimer's disease

One of the many mysteries of Alzheimer's disease is how protein-like snippets called amyloid-beta peptides, which clump together to form plaques in the brain, may cause cell death, leading to the disease's devastating symptoms of memory loss and other mental difficulties.

5 Nov 2009

Surgery may not be the best option for children with obstructive sleep apnea

For children with obstructive sleep apnea, standard care often includes a tonsillectomy and adenoidectomy. But researchers at Saint Louis University say further research is needed to determine if surgery is the best option for these patients.

5 Nov 2009

Imagenetix awarded U.S. patent for its 1-TDC drug candidate to treat periodontal disease

Imagenetix, Inc., announced today the issuance of a new U.S. patent (No. 7,612,111). The patent provides intellectual property protection for Imagenetix's 1-TDC early stage drug candidate for the prevention and treatment of periodontal disease.

5 Nov 2009

Green tea extract shows promise as cancer prevention agent for oral cancer, reveal researchers

Green tea extract has shown promise as cancer prevention agent for oral cancer in patients with a pre-malignant condition known as oral leukoplakia, according to researchers at The University of Texas M. D. Anderson Cancer Center.

5 Nov 2009

New paper-strip test for detecting pesticides in beverage and food samples

Scientists in Canada are reporting the development of a fast, inexpensive "dipstick" test to identify small amounts of pesticides that may exist in foods and beverages. Their paper-strip test is more practical than conventional pesticide tests, producing results in minutes rather than hours by means of an easy-to-read color-change, they say.

5 Nov 2009

People with MS who relapse within first five years of onset have more severe disability: Study

People with multiple sclerosis (MS) who have relapses within the first five years of onset appear to have more severe disability in the short term compared to people who do not have an early relapse, according to a new study published in the November 4, 2009, issue of Neurology®, the medical journal of the American Academy of Neurology. The study is one of the first to examine how MS relapses affect people during different time periods of the disease.

5 Nov 2009

NIAID funds CCHI and IMVC programs to help identify new vaccines for emerging infectious diseases

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded approximately $208 million to two programs that support research to better understand the human immune response to emerging and re-emerging infectious diseases, including those that may be introduced into a community through acts of bioterrorism.

5 Nov 2009

USPTO awards Peregrine Pharmaceuticals patent for anti-viral uses of phosphatidylserine targeting antibodies

Peregrine Pharmaceuticals, Inc. today announced that the U.S. Patent and Trademark Office has issued U.S. Patent Number 7,611,704, which includes broad claims covering anti-viral uses of phosphatidylserine (PS)-targeting antibodies including Peregrine's lead clinical compound, bavituximab. PS is a unique marker exposed on the surface of virally infected cells that can be targeted to treat a broad spectrum of virus infections.

5 Nov 2009

Micro-injector may help rapid development of new generation of drugs

It's no bigger than a stamp packet but it has the potential to allow rapid development of a new generation of drugs and genetic engineering organisms, and to better control in-vitro fertilization.

5 Nov 2009

New Merck set to begin global health care operations

Merck & Co., Inc. today outlined its global plans following the completion of Merck's merger with Schering-Plough Corporation announced yesterday. The new Merck is a global health care leader aimed at providing innovative, distinctive products and services that save and improve lives, while satisfying customer needs and creating long term shareholder value.

5 Nov 2009

Medical News

Oral contraceptives may have a potential role in the management of premenopausal women with asthma

InterMune seeks FDA marketing approval for pirfenidone

Savvis incorporates Vitality's wellness program to help improve employees’ health challenges

Yoga may be more effective for reducing chronic low back pain, say researchers

Raptor Pharmaceutical to present oral AMPA-kainate antagonist data at the neuropathic pain conference

Patient enrollment in three late-stage clinical trials completed

Significant behavioral changes needed to maintain weight loss

AAHC urges Senator Harry Reid to incorporate its recommendations in the health reform legislation

Herbalife establishes new business in Vietnam; Paraguay operations set to begin shortly

Tetracycline-like compound raises hope for treatment of spinal muscular atrophy

Researchers develop new molecular tools to investigate Alzheimer's disease

Surgery may not be the best option for children with obstructive sleep apnea

Imagenetix awarded U.S. patent for its 1-TDC drug candidate to treat periodontal disease

Green tea extract shows promise as cancer prevention agent for oral cancer, reveal researchers

New paper-strip test for detecting pesticides in beverage and food samples

People with MS who relapse within first five years of onset have more severe disability: Study

NIAID funds CCHI and IMVC programs to help identify new vaccines for emerging infectious diseases

USPTO awards Peregrine Pharmaceuticals patent for anti-viral uses of phosphatidylserine targeting antibodies

Micro-injector may help rapid development of new generation of drugs

New Merck set to begin global health care operations

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News